KALISTA ENGELMAN, DO

Administration of chemotherapy into vein, 1 hour or less

New patient office or other outpatient visit, 45-59 minutes

Established patient office or other outpatient visit, 30-39 minutes

Dxa bone density measurement of hip, pelvis, spine

New patient office or other outpatient visit, 30-44 minutes

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Injection, rituximab, 10 mg

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage

Established patient office or other outpatient visit, 20-29 minutes

Tuberculosis test, gamma interferon

Established patient office or other outpatient visit, 10-19 minutes

Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

X-ray of knee, 3 views

X-ray of hand, minimum of 3 views

Injection, infliximab, excludes biosimilar, 10 mg

Administration of chemotherapy into vein, each additional hour

Injection of drug or substance under skin or into muscle

Injection of additional new drug or substance into vein

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Injection, denosumab, 1 mg

Measurement of complement (immune system proteins), antigen,

Administration of influenza virus vaccine

Measurement of antibody for rheumatoid arthritis assessment

Injection, golimumab, 1 mg, for intravenous use

Blood test, comprehensive group of blood chemicals

Injection, methylprednisolone acetate, 80 mg

Liver function blood test panel

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Gammaglobulin (immune system protein) measurement

Creatine kinase (cardiac enzyme) level, total

Rheumatoid factor level

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Measurement c-reactive protein for detection of infection or inflammation

Blood creatinine level

Injection, tocilizumab, 1 mg

Red blood cell sedimentation rate, to detect inflammation, non-automated

Uric acid level, blood

Insertion of needle into vein for collection of blood sample